HUMA   $4.47  2.05% Market Closed After Close 4.4 -1.57%

Humacyte Inc
Total Cash 93.56M
totalCashPerShare 0.784
EBITDA -99.65M
Total Debt 18.93M
quickRatio 5.269
currentRatio 5.413
Total Revenue
debtToEquity
Revenue/Share
ROA -0.43605
ROE -8.50807
grossProfits
freeCashflow -49.98M
operatingCashflow -80.70M
earningsGrowth
revenueGrowth
grossMargins 0.0
ebitdaMargins 0.0
operatingMargins 0.0
profitMargins 0.0
enterpriseValue 573.45M
forwardPE -6.464286
floatShares 86.37M
sharesOutstanding 125.33M
sharesShort 16.68M
sharesShortPriorMonth 14.01M
dateShortInterest
sharesPercentSharesOut 0.13%
heldPercentInsiders 0.28%
heldPercentInstitutions 0.26%
Short Ratio help_outline 6.18%
shortPercentOfFloat 0.17%
impliedSharesOutstanding
bookValue -0.237
Price To Book help_outline
earningsQuarterlyGrowth
netIncomeToCommon -139.66M
trailingEps -1.32%
forwardEps -0.84%
enterpriseToEbitda -5.75
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.25 3Q 2024
institutionsCount 175
lastUpdated Nov. 7, 2024, 5:15 a.m.